Install
The analyzed dataset included over 200,000 patients with vitiligo to find trends in diagnosis, treatment, and more. The findings of the MVOR-1 and MVOR-2 studies are published in JAMA Dermatology, supporting the rosacea drug’s recent FDA approval. Serota and other field experts discussed best practices as well as new t
- 10articles · 30d
- 4+ day agolatest article
- Aug 18, 2026earliest in window
- 100%with images
- 221avg words
- Medical 10
- Health 9
- Health & Wellness 7
- Beauty & Fitness 3
- Education 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Biologic Therapy Linked to Lower 10-Year MACE Risk Across Racial Groups in Psoriasis
6+ day, 22+ hour ago (350+ words) Patients receiving biologic therapy were compared with psoriasis patients who had not received biologics...After 1:1 propensity score matching, each cohort included 36,330 patients....Over 10 years, 2160 patients in the biologic-treated cohort experienced a MACE compared with 3294 patients...The authors concluded that the…...
How Aging Affects Psoriasis Presentation and Treatment Decisions
3+ week, 5+ day ago (395+ words) MD, discussed how aging affects psoriasis presentation and the insurance challenges facing older patients...aging shapes every level of dermatologic practice, from basic science and pathophysiology to how patients...He cautioned against treating older and younger patients as clinically interchangeable,…...